# Topical TOR-582 Treatment of Epistaxis in HHT

> **NCT07667413** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Columbia University** · enrollment: 27 (estimated)

## Conditions studied

- Hereditary Hemorrhagic Telangiectasia (HHT)
- Epistaxis

## Interventions

- **DRUG:** Topical sirolimus ointment

## Key facts

- **NCT ID:** NCT07667413
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2026-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07667413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07667413, "Topical TOR-582 Treatment of Epistaxis in HHT". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07667413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*